Nexium

Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC

Bioequivalence Study of Esomeprazole From Stomopral 40 mg Capsules Contain Enteric Coated Pellets (Future Pharmaceuticals Industries, Egypt) and Nexium 40 mg Delayed Release Capsules (AstraZeneca Sweden, Product of France)

Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy

PK/PD Clinical Trial of YYD601 in Healthy Adult Male

Safety Trial of Herbal Melanin in Gastritis Patients

A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects

Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori Infection

Levofloxacin-containing Therapies In Second Line Helicobacter Pylori Eradication

Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression

Bioequivalence of Two Formulations of Esomeprazole

Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.

The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy Subjects

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

Which Supraesophageal Reflux Symptoms Reliably Respond to Proton-Pump-Inhibitor (PPI) Therapy